Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients

@inproceedings{Pistelli2015PretreatmentNT,
  title={Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients},
  author={Mirco Pistelli and Mariagrazia De Lisa and Zelmira Ballatore and Miriam Caramanti and Alessandra Pagliacci and Nicola Battelli and Francesca Ridolfi and Matteo Santoni and Elena Maccaroni and Raffaella Bracci and Alfredo Santinelli and Tommasina Biscotti and Rossana Berardi and Stefano Cascinu},
  booktitle={BMC Cancer},
  year={2015}
}
There is a growing body of evidence that immune response plays a large role in cancer outcome. The neutrophil to lymphocyte ratio (NLR) has been used as a simple parameter of systemic inflammation in several tumors. The purpose was to investigate the association between pre-treatment NLR, disease-free survival and overall survival in patients with early triple negative breast cancer (TNBC). We reviewed the records of patients with stage I-III TNBC at our Institution from 2006 to 2012. The… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS